Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study

Ulrich Christian Bang; Shakil A Shakar; Mette Friberg Hitz; Mette Syberg Jespersen; Ove Andersen; Susanne Dam Poulsen; Jens-Erik Beck Jensen

doi:10.3109/00365540903463981

Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study

Ulrich Christian Bang, Shakil A Shakar, Mette Friberg Hitz, Mette Syberg Jespersen, Ove Andersen, Susanne Dam Poulsen, Jens-Erik Beck Jensen

Department of Clinical Medicine

35 Citations (Scopus)

Abstract

The aim of this descriptive cross-sectional study was to describe the prevalence of hypovitaminosis D in a cohort of HIV-seropositive males. Blood samples were collected in November and December 2004 and analyzed in the hospital laboratory. The concentration of 25-hydroxyvitamin D (25(OH)D) was defined as excellent when >75 nmol/l, normal when >50 nmol/l, insufficient when <50 nmol/l, deficient when <25 nmol/l and severely deficient when <12.5 nmol/l. Patient information was extracted from the medical records. A total of 115 males, median age 44 y (range 1963 y), were included in the study. The median 25(OH)D concentration was 43.0 nmol/l (range 8163 nmol/l) and the 25(OH)D level was excellent in 13%, normal in 27%, insufficient in 36%, deficient in 20%, and severely deficient in 4% of the cases. Vitamin D level was not associated with age, y with HIV infection, highly active antiretroviral therapy (HAART) or CD4 count. Compared to patients not in treatment, patients on HAART (n 71) had higher levels of total alkaline phosphatase (median 83.0 vs 75.5 U/l; p 0.031) and lower, though not significantly, total body mineral density (1.055 vs 1.107 g/cm²; p 0.077). This study confirms that the prevalence of hypovitaminosis is high among HIV-infected patients.

Original language	English
Book series	Scandinavian Journal of Infectious Diseases. Supplementum
Volume	42
Issue number	4
Pages (from-to)	306-10
Number of pages	5
ISSN	0300-8878
DOIs	https://doi.org/10.3109/00365540903463981
Publication status	Published - 1 Apr 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/00365540903463981

Cite this

@article{2f0c1d32ab854b1a98c67391b843b10a,

title = "Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study",

abstract = "The aim of this descriptive cross-sectional study was to describe the prevalence of hypovitaminosis D in a cohort of HIV-seropositive males. Blood samples were collected in November and December 2004 and analyzed in the hospital laboratory. The concentration of 25-hydroxyvitamin D (25(OH)D) was defined as excellent when >75 nmol/l, normal when >50 nmol/l, insufficient when <50 nmol/l, deficient when <25 nmol/l and severely deficient when <12.5 nmol/l. Patient information was extracted from the medical records. A total of 115 males, median age 44 y (range 1963 y), were included in the study. The median 25(OH)D concentration was 43.0 nmol/l (range 8163 nmol/l) and the 25(OH)D level was excellent in 13%, normal in 27%, insufficient in 36%, deficient in 20%, and severely deficient in 4% of the cases. Vitamin D level was not associated with age, y with HIV infection, highly active antiretroviral therapy (HAART) or CD4 count. Compared to patients not in treatment, patients on HAART (n 71) had higher levels of total alkaline phosphatase (median 83.0 vs 75.5 U/l; p 0.031) and lower, though not significantly, total body mineral density (1.055 vs 1.107 g/cm2; p 0.077). This study confirms that the prevalence of hypovitaminosis is high among HIV-infected patients.",

author = "Bang, {Ulrich Christian} and Shakar, {Shakil A} and Hitz, {Mette Friberg} and Jespersen, {Mette Syberg} and Ove Andersen and Poulsen, {Susanne Dam} and Jensen, {Jens-Erik Beck}",

year = "2010",

month = apr,

day = "1",

doi = "10.3109/00365540903463981",

language = "English",

volume = "42",

pages = "306--10",

journal = "Scandinavian Journal of Infectious Diseases, Supplement",

issn = "0300-8878",

publisher = "Taylor & Francis",

number = "4",

}

TY - JOUR

T1 - Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study

AU - Bang, Ulrich Christian

AU - Shakar, Shakil A

AU - Hitz, Mette Friberg

AU - Jespersen, Mette Syberg

AU - Andersen, Ove

AU - Poulsen, Susanne Dam

AU - Jensen, Jens-Erik Beck

PY - 2010/4/1

Y1 - 2010/4/1

N2 - The aim of this descriptive cross-sectional study was to describe the prevalence of hypovitaminosis D in a cohort of HIV-seropositive males. Blood samples were collected in November and December 2004 and analyzed in the hospital laboratory. The concentration of 25-hydroxyvitamin D (25(OH)D) was defined as excellent when >75 nmol/l, normal when >50 nmol/l, insufficient when <50 nmol/l, deficient when <25 nmol/l and severely deficient when <12.5 nmol/l. Patient information was extracted from the medical records. A total of 115 males, median age 44 y (range 1963 y), were included in the study. The median 25(OH)D concentration was 43.0 nmol/l (range 8163 nmol/l) and the 25(OH)D level was excellent in 13%, normal in 27%, insufficient in 36%, deficient in 20%, and severely deficient in 4% of the cases. Vitamin D level was not associated with age, y with HIV infection, highly active antiretroviral therapy (HAART) or CD4 count. Compared to patients not in treatment, patients on HAART (n 71) had higher levels of total alkaline phosphatase (median 83.0 vs 75.5 U/l; p 0.031) and lower, though not significantly, total body mineral density (1.055 vs 1.107 g/cm2; p 0.077). This study confirms that the prevalence of hypovitaminosis is high among HIV-infected patients.

AB - The aim of this descriptive cross-sectional study was to describe the prevalence of hypovitaminosis D in a cohort of HIV-seropositive males. Blood samples were collected in November and December 2004 and analyzed in the hospital laboratory. The concentration of 25-hydroxyvitamin D (25(OH)D) was defined as excellent when >75 nmol/l, normal when >50 nmol/l, insufficient when <50 nmol/l, deficient when <25 nmol/l and severely deficient when <12.5 nmol/l. Patient information was extracted from the medical records. A total of 115 males, median age 44 y (range 1963 y), were included in the study. The median 25(OH)D concentration was 43.0 nmol/l (range 8163 nmol/l) and the 25(OH)D level was excellent in 13%, normal in 27%, insufficient in 36%, deficient in 20%, and severely deficient in 4% of the cases. Vitamin D level was not associated with age, y with HIV infection, highly active antiretroviral therapy (HAART) or CD4 count. Compared to patients not in treatment, patients on HAART (n 71) had higher levels of total alkaline phosphatase (median 83.0 vs 75.5 U/l; p 0.031) and lower, though not significantly, total body mineral density (1.055 vs 1.107 g/cm2; p 0.077). This study confirms that the prevalence of hypovitaminosis is high among HIV-infected patients.

U2 - 10.3109/00365540903463981

DO - 10.3109/00365540903463981

M3 - Journal article

SN - 0300-8878

VL - 42

SP - 306

EP - 310

JO - Scandinavian Journal of Infectious Diseases, Supplement

JF - Scandinavian Journal of Infectious Diseases, Supplement

IS - 4

ER -

Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this